Virtu Financial LLC Leap Therapeutics, Inc. Transaction History

Virtu Financial LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	SELL	$0.42 - $9.18 $26,591 - $581,213	-63,313 Reduced 81.57%	14,303 $6,000
Q3 2022 Nov 07, 2022	BUY	$0.92 - $9.3 $44,850 - $453,384	48,751 Added 168.89%	77,616 $68,000
Q2 2022 Aug 09, 2022	BUY	$0.96 - $1.91 $8,497 - $16,907	8,852 Added 44.23%	28,865 $33,000
Q1 2022 May 17, 2022	BUY	$1.6 - $3.35 $32,020 - $67,043	20,013 New	20,013 $35,000
Q4 2021 Feb 17, 2022	SELL	$2.08 - $3.65 $682,674 - $1.2 Million	-328,209 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$1.35 - $4.01 $443,082 - $1.32 Million	328,209 New	328,209 $1.32 Million
Q2 2021 Sep 17, 2021	SELL	$1.48 - $1.92 $24,940 - $32,355	-16,852 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$1.82 - $3.01 $30,670 - $50,724	16,852 New	16,852 $32,000
Q4 2019 Feb 04, 2020	SELL	$0.63 - $1.37 $14,819 - $32,226	-23,523 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$1.17 - $2.36 $27,521 - $55,514	23,523 New	23,523 $28,000
Q2 2019 Aug 13, 2019	SELL	$1.36 - $2.07 $24,439 - $37,197	-17,970 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$1.39 - $3.07 $5,771 - $12,746	4,152 Added 30.05%	17,970 $34,000
Q4 2018 Jan 16, 2019	BUY	$1.92 - $7.94 $26,530 - $109,714	13,818 New	13,818 $28,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $239M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.